Remove tag equality
article thumbnail

Machine learning hiring levels in the pharmaceutical industry rose in June 2022

Pharmaceutical Technology

Our analysis of the data shows that pharmaceutical companies are currently hiring for machine learning jobs at a rate equal to the average for all companies within GlobalData's job analytics database. The average among all companies stood at 1.2% in June 2022.

233
233
article thumbnail

Grand Rounds December 15, 2023: Diversifying Clinical Trials: A Path Forward (Roxana Mehran, MD, FACC, FAHA, MSCAI, FESC)

Rethinking Clinical Trials

Diversity in clinical trials is important for generalizability of results, to provide equal opportunities, practice precision medicine, tailor practical guidelines, improve public health outcomes, detect potential differences in safety and efficacy, and to address health disparities. We need to think about removing some of this and evaluate.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Grand Rounds March 10, 2023: Estimands in Cluster-Randomized Trials: Choosing Analyses that Answer the Right Question (Brennan Kahan, PhD)

Rethinking Clinical Trials

Equal cluster size does not necessarily mean that estimand is irrelevant because of differences in sample size. Reweighting may be necessary, and there may be additional assumptions. – It’s difficult to determine definitively if there is informative cluster size, but it would be interesting to evaluate in pilot data clusters.

Trials 130
article thumbnail

Grand Rounds April 21, 2023: Personalised Cooler Dialysate for Patients Receiving Maintenance Haemodialysis (MyTEMP): A Pragmatic, Cluster-randomised Trial (Amit Garg, MD, MA, FRCPC, FACP, PhD; Stephanie N. Dixon, PhD MSc)

Rethinking Clinical Trials

In a recent international survey of more than 270 centers, nearly half now use a cooler temperature dialysate in patient care of less than or equal to 36.0 Where the risks and benefits are equal, but I wouldn’t want to be randomly assigned. This change in practice is based on data that suggests the at cooler (vs.

Trials 130
article thumbnail

Grand Rounds July 8, 2022: Results From the COVID-OUT Trial, A Phase-3 Trial of Outpatient Treatment for Covid-19 Using Metformin, Ivermectin, and Fluvoxamine (Carolyn Bramante, MD, MPH; Thomas Murray, PhD; Jared Huling, PhD)

Rethinking Clinical Trials

We also kept equal focus on follow-up. We worked together between the sites when there were issues with bandwidth at one of the sites, the main site would call those participants. Learn more about COVID-OUT. pctGR, @Collaboratory1.

Trials 130
article thumbnail

Grand Rounds February 9, 2024: Pragmatic Recruitment of Underrepresented Groups – Experience From the Diuretic Comparison Project (Cynthia Hau, MPH)

Rethinking Clinical Trials

. – Regarding the critical importance of the health system as one of the take homes from your talk, do you encounter heterogeneity within the VA health system for “buy in” to participate in the trial or do all VA health systems cooperate equally? We did the study at 72 medical centers and encountered 72 different themes within the EHR.

article thumbnail

Grand Rounds February 16, 2024: Clinical Implications of the MINT Trial: p=0.07 (Jeffrey Carson, MD, MACP)

Rethinking Clinical Trials

For the liberal strategy, 1 unit of packed red blood cells were administered following randomization, and red blood cells were transfused to maintain a hemoglobin concentration greater than or equal to 10 g/dL through hospital discharge or 30 days. There were 3 primary limitations of the MINT trial.

Trials 130